Argos Therapeutics, Inc. filed a voluntary petition for reorganization under Chapter 11 in the US Bankruptcy Court for the District of Delaware on November 30, 2018. The debtor listed its assets of $10.88 million and liabilities of $23.45 million. Matthew B. McGuire of Landis Rath & Cobb LLP acted as legal counsel, SSG Advisors, LLC acted as investment banker and Wilmer Cutler Pickering Hale and Dorr LLP as special corporate counsel for the debtor. Matthew Foster of Sonoran Capital Advisors, LLC represent as chief restructuring officer for the debtor.